Eurazeo Shares Hit a Five-Year Low at 38.98 Euros, Down 46% in One Year
This Friday, Eurazeo hit a new five-year low, recording a drop to 38.98 euros during the session. The investment company's stock fell by 2.5% compared to the previous day, amidst a general decline in the Paris stock market. The downward trajectory is accelerating, with a decline of over 46% over the past year.
Technical Breakdown as Eurazeo Falls Below Previous Five-Year Low
Eurazeo's stock price has fallen below its previous five-year low, set at 39.22 euros on March 11th, reaching 38.98 euros this Friday. This downward breach serves as an unfavorable technical signal. The stock is now significantly below its 50-day and 200-day moving averages, which are at 48.34 euros and 54.58 euros respectively, indicating a firmly entrenched downward trend across multiple time horizons. The Relative Strength Index (RSI) at 21 is deeply embedded in the oversold zone, a rarely seen level indicating a pronounced selling excess. However, this extreme positioning does not necessarily predict a rebound, in the absence of any short-term identifiable catalyst. The previous support at 39.70 euros did not hold, leaving the stock without immediate technical support on the downside. Over the past seven days, Eurazeo has lost 4.18%, bringing the three-month decline to 25.54%.
Market Tensions Amid Energy Shock Impact European Sessions
This Friday's session took place amid tensions in European markets. The CAC 40 fell by 1.40% during the session, reaching 7,698 points, while the SBF 120 dropped by 1.39%. This selling pressure is part of a context of an energy shock related to the conflict in the Middle East: Brent crude oil surpassed 107 dollars, up 50% since the end of February, fueling fears of an inflationary resurgence and economic slowdown. For an investment and management company like Eurazeo, the deterioration of the macroeconomic environment can affect both portfolio valuations and the prospects for asset disposals. The financial calendar includes the general assembly on May 6th, followed by the publication of first-quarter revenue on May 13th. These dates will provide concrete elements on the health of the group's holdings and the strategy for capital deployment in this uncertain environment.
